ABSTRACT
Introduction
Intervertebral disc herniation may allow the contents of the nucleus pulposus to extravasate. This content is rich in phospholipase-A, a potent inflammatory mediator that may be responsible for the pain process in the dorsal pain.1 Corticosteroids have been used epidurally for treating lumbosciatic pain with a relatively secure profile for a long time, 2, 3, 4, 5, 6, 7, 8 however some controversy does exist. 9 The corticosteroids use thru intrathecal route has been associated with severe nervous system complications, such as adhesive arachnoiditis (AA). This complication is more likely to happen when depo-corticoids, such as methylprednisolone, are used. 10, 11, 12, 13 When an epidural block is performed there is calculated risk of 5% of inadvertent intrathecal puncture, 14 which makes neural axis use of these medications less secure. The justifications for the injection of corticoids in the epidural route are their maximum antiinflammatory action close to the affected nerve root with lower systemic effects, although there are many reports in literature of the risks of Cushing syndrome and other complications. 8, 15, 16, 17 AA is a severe and rare complication characterized by bladder and intestinal dysfunction, loss of sensibility, and weakness. The clinical features resemble cauda equina syndrome but the symptoms begin in a slower manner and they may result in paraplegia and death. 18, 19, 20 The histological characteristics are proliferation and fibrosis of the leptomeninges with obliteration of the intrathecal space, deformation of the nervous roots, and spinal cord constriction. 18, 21, 22, 23 Concerned with the many AA cases reported by Australian physicians, The Medical Defence Union of New South Wales, Australia, released a warning recommending that corticosteroids should no longer be used in the epidural space. 12, 24 Ten years later, the use of corticoids in the epidural space was recognized as safe in a review supported by The Australian Pain Society, although the authors do not "recommend" its use. 25 There is a need to find new and safer agents, as an optional to the methylprednisolone, to be used in the epidural space for treating lumbosciatic pain 26 . Betamethasone would be a good option since it is a hydrophilic agent with no clinical complications reported from its use in the epidural space. Latham et al. 27 administered different doses of betamethasone in the intrathecal space of sheeps. They could only observe nervous tissue injuries when doses above those clinically recommended were injected. 27 In dogs, an animal model used to study some agents toxicity, there are no reports of neurological harm from betamethasone. 20 The objective of this study is to determine the effects of two different betamethasone doses injected in the canine intrathecal space.
Methods
After approval by The Animal Research Ethics Committee of this University, and following the Animal Experimentation Ethics, 21 adult dogs of both genders, weighing between eight and 17kg and spinal lengths between 60 and 70cm, were enrolled in the study. They were randomly located into 3 experimental groups differentiated by the solution to be spinally administered: G1 -saline isotonic solution (1ml); G2 -betamethasone 1.75mg (1ml); G3 -betamethasone 3mg (1ml). Following a 12 hour fasting period with free access to water, the dogs were anesthetized with intravenous fentanyl 0.005mg.kg -1 and etomidate 2mg.kg -1 . They were placed on a Claude Bernard's trough and the distance between occipital protuberance and lumbosacral space was measured to obtain the spinal length. The skin and the hair at the puncture site were cleaned with soap and water. Then an area of approximately 10cm around the L6-L7 interspace was shaved, washed with sterile saline solution, and disinfected with 2% clorexidine solution. Sterilized drapes were placed around the disinfected area. To perform the spinal puncture, the two tuberosities of the iliac bone and of the spinal process of the last lumbar vertebra were identified. The lumbosacral space was located immediately below. By sliding the finger in the cephalic direction, the next inter-vertebra space was L6-L7; this was the site where the puncture was performed using a disposable 25G Quincke needle which was inserted through median access at approximately 45°. After crossing the arachnoids membrane, the needle mandrel was removed to obtain free CSF leakage -proof of correct needle placement. The blinded solution was then injected. After puncture procedure, and recovery from intravenous anesthesia, the dogs were clinically observed by evaluating anal sphincter relaxation, presence of hind limb paralysis and testing for painful sensitivity in different dermatomes, such as the hind and front interdigital membrane, the tail, the cervical, the thoracic, the lumbar and the sacral dermatomes. A mousetooth forceps was used for sensitivity evaluation. The dogs were then observed for a 21 days period evaluating: anal sphincter relaxation, hind limb movement, ability to move the tail, and changes in sensitivity to pain. After this observational period, animals were given intravenous anesthesia and then sacrificed by electrocution. The lumbar and sacral portions of the spinal cord were removed in less than three minutes and immediately fixed in 10% formalin solution. Nerve tissue and meninges fragments were ressected at 1cm intervals, beginning approximately 5cm above puncture site to the end of the cauda equine. Sections were dyed with the hematoxilin-eosin stain method. Blinded evaluation was performed by the pathologist. Analysis of variance (ANOVA) was used to evaluate group homogeneity in terms of weight and spinal length; p<0.05 was considered significant.
Results
There were no significant differences in the animals weight (F=1.1; p=0.35) and spinal length (F=0.31; p=0.73) (Table 1) between the studied groups. None of the animals showed any kind of neurological changes (sensitivity, mobility, or sphincter function). Although no histological changes were observed by light microscopy in the animals from G1 (Figure 1) , two animals in G2, and two animals in G3 showed meningeal and nerve tissue lesions (Tables  2 and 3 ) -three with fibrous thickening of the meningeal layer ( Figure 2 ) and two with inflammatory cells (Figure 3 ). Nerve tissue necrosis was seen in one G2 animal (Figure 3 ).
Discussion
The dog was the chosen animal for this research since some toxicity studies have been successfully performed in this animal. These studies closely reproduce what happens in human beings. The anatomy of the dog permits easy performance of spinal block, with a low risk of puncture accidents. Methyprednisolone is currently one of the most common corticoids used for treating lumbosciatic pain by spinal route, despite relates of occurrence of AA, probably due to the presence of polyethylene glycol in its formulation. 10, 11, 12, 13, 28, 29, 30, 31 Betamethasone is an alternative to methylprednisolone since there are no reports of neural toxicity in humans and because it is a potent corticoid without mineralcorticoidal effects. It is about five times as potency as methylprednisolone, which is why the doses used were within those recommended for therapeutic proposals, i.e. 0.22 mg.kg-1. No clinical changes were observed during the experimental period, although tissue lesions were present. Joseph and Denson 32 performed a study in monkeys, using different quantities of detergents injected into the intrathecal space. Two animals had severe histological changes, but only one of them had clinical symptoms of the disease. 32 Similar results were found by different researchers using different animal models, where clinical findings did not relate to the degree of histological changes. 20, 33, 34 As AA develops very slowly, the neurological symptoms may be present only after a long period of evolution, reason perhaps the dogs in this study did not present any clinical findings during the experimental period of 21 days. The puncture technique was not responsible for the lesions observed in the G2 and G3 animals, since G1 animals presented no abnormalities at histological exam. Four animals from the two betamethasone groups presented histological changes. Betamethasone is a depo-corticoid with a long half-life. This means that it could have a long contact period with the nerve tissue and it allows a good distribution on the spinal cord surface. The densities of betamethasone injected solutions were 1007 and 1009 (G2 and G3 respectively). CRF has a density of 1003-1009. As density correlates with baricity it is possible to conclude that the injected solutions are isobaric, which may help their cephalic distribution. 35 The necrosis in the G2 animal extended from the meningeal to peripheral spinal nervous tissue, location where the contact of the injected solution happens in a closer manner. The histological changes seem in the other animals are likely to be more important in the meningeal layer, displaying thickness with associated inflammatory process. This may indicate AA, a disease with the characteristics of an inflammatory process and posterior thickness of the arachnoids layer. 36 There are many causes of AA, including radiological contrasts, bacterial and viral infections, detergents, and corticoids. Goldstein et al. 37 , in 1970, performed a clinical study with intrathecal methylprednisolone in 38 patients. Only one of them presented clinical AA. Since this study, the risk of methylprednisolone spinal administration has become a concern to physicians. 38 One special concern is the addition of the polyethylene glycol in the commercially available methylprednisolone solutions, in the betamethasone solutions and in many others corticosteroids. It is added to the corticoid solutions to increase its solubility properties and it may be responsible for the reports of AA associated with methylprednisolone use. 10, 11, 12, 13, 29, 30, 31, 39 Selby 40 , observed immediate desmielinization process when polyethylene glycol was injected in rat and rabbit peripheral nerves, optical nerve, spinal cord, and nerve root. 40 Latham et al. 27 , only observed AA in sheep when betamethasone doses much higher than those recommended in clinical use were injected. Benzoic alcohol is another compound found in the commercial betamethasone solution used in this study. It is a preservative with anti-microbial properties, and known neurotoxicity. 41 The exposition of paw nerve of rats to solutions containing polyethylene glycol and benzoic alcohol, for periods longer than one hour, resulted in permanent lesions and degeneration. 42 But, at the concentrations they are found in the commercial preparations, they are not likely to cause nerve toxicity. 41, 43 However, the betamethasone doses injected in this study showed an ability to cause histological changes in the meninges and spinal cords of some dogs enrolled in this research.
Conclusion
The betamethasone solution injected in the intrathecal space, in this experimental model, determined histological changes in the meninges and spinal cord of dogs.
